FDA Inspection 1082722 — Sharplight Technologies
The FDA completed an inspection of Sharplight Technologies on February 14, 2019 in Rishon Le-Tsiyon. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 14, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Rishon Le-Tsiyon (Israel)